CGEN
Compugen
NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY
$2.47
+0.41% today
Updated 2026-09-11
Market cap
$233.97M
P/E ratio
6.50
P/S ratio
3.16x
EPS (TTM)
$0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.3M
Compugen (CGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.47
12-Month target
$2.06
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 6.50x (capped 25x) · Margin: 47.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.